Xavier Durand

1.9k total citations
95 papers, 1.1k citations indexed

About

Xavier Durand is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Rheumatology. According to data from OpenAlex, Xavier Durand has authored 95 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Surgery, 44 papers in Pulmonary and Respiratory Medicine and 28 papers in Rheumatology. Recurrent topics in Xavier Durand's work include Urologic and reproductive health conditions (23 papers), Testicular diseases and treatments (20 papers) and Prostate Cancer Diagnosis and Treatment (19 papers). Xavier Durand is often cited by papers focused on Urologic and reproductive health conditions (23 papers), Testicular diseases and treatments (20 papers) and Prostate Cancer Diagnosis and Treatment (19 papers). Xavier Durand collaborates with scholars based in France, Lebanon and United States. Xavier Durand's co-authors include Évanguelos Xylinas, Alexandre de la Taille, Laurent Salomon, Yves Allory, Stéphane Moutereau, Dimitri Vordos, Guillaume Ploussard, Francis Vacherot, András Hoznek and Philippe Camparo and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and The Journal of Urology.

In The Last Decade

Xavier Durand

82 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xavier Durand France 17 515 509 217 204 158 95 1.1k
Sean P. Stroup United States 21 404 0.8× 970 1.9× 211 1.0× 301 1.5× 54 0.3× 71 1.3k
Jeffrey Tomaszewski United States 24 348 0.7× 704 1.4× 97 0.4× 310 1.5× 110 0.7× 82 1.1k
Yasuyuki Kobayashi Japan 18 456 0.9× 359 0.7× 70 0.3× 159 0.8× 29 0.2× 132 964
Cenk Yücel Bilen Türkiye 18 255 0.5× 660 1.3× 57 0.3× 147 0.7× 54 0.3× 73 973
Marcus Horstmann Germany 16 725 1.4× 369 0.7× 177 0.8× 191 0.9× 70 0.4× 77 1.3k
Marian S. Wettstein Switzerland 14 214 0.4× 405 0.8× 128 0.6× 55 0.3× 65 0.4× 52 636
John Pattaras United States 20 333 0.6× 773 1.5× 74 0.3× 242 1.2× 124 0.8× 73 1.2k
C.C. Abbou France 14 540 1.0× 866 1.7× 255 1.2× 147 0.7× 62 0.4× 27 1.3k
Daniel Liberman Canada 19 533 1.0× 480 0.9× 257 1.2× 142 0.7× 43 0.3× 60 1.0k
Amy L. Tin United States 16 329 0.6× 387 0.8× 76 0.4× 125 0.6× 164 1.0× 91 1.0k

Countries citing papers authored by Xavier Durand

Since Specialization
Citations

This map shows the geographic impact of Xavier Durand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xavier Durand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xavier Durand more than expected).

Fields of papers citing papers by Xavier Durand

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xavier Durand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xavier Durand. The network helps show where Xavier Durand may publish in the future.

Co-authorship network of co-authors of Xavier Durand

This figure shows the co-authorship network connecting the top 25 collaborators of Xavier Durand. A scholar is included among the top collaborators of Xavier Durand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xavier Durand. Xavier Durand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Garnier, Jonathan, Anaïs Palen, Xavier Durand, et al.. (2025). Immediate variations in high‐dimensional circulating immune cells following pancreatectomy. Clinical & Translational Immunology. 14(11). e70059–e70059.
2.
Durand, Xavier, et al.. (2025). Utility of MRI in NMIBC and feasibility of avoiding Re-TURB in carefully selected patients: a systematic review. World Journal of Urology. 43(1). 95–95. 1 indexed citations
3.
Pinar, Ugo, Xavier Durand, Ambroise Salin, et al.. (2024). Patients and general practitioner knowledge and perception of testicular self-examination for cancer. World Journal of Urology. 42(1). 58–58.
4.
Durand, Xavier, et al.. (2020). Glans penis augmentation using hyaluronic acid for the treatment of premature ejaculation: a narrative review. Translational Andrology and Urology. 9(6). 2814–2820. 12 indexed citations
5.
Durand, Xavier, et al.. (2018). Management of Lindbom's hernia (ureterosciatic hernia). Journal of Visceral Surgery. 156(4). 366–367. 5 indexed citations
6.
Durand, Xavier, Aude Fléchon, T. Murez, et al.. (2016). Recommandations en onco-urologie 2016-2018 du CCAFU : Tumeurs germinales testiculaires. Progrès en Urologie. 27. S147–S165. 7 indexed citations
7.
Hornez, E., et al.. (2015). Grade IV renal trauma management. A revision of the AAST renal injury grading scale is mandatory. European Journal of Trauma and Emergency Surgery. 42(2). 237–241. 19 indexed citations
8.
Avancès, C., Philippe Camparo, Xavier Durand, et al.. (2014). Prise en charge des tératomes testiculaires : mise au point par le Comité de cancérologie de l’Association française d’urologie groupe organes génitaux externes (CCAFU-OGE). Progrès en Urologie. 24(16). 1050–1053. 1 indexed citations
9.
Avancès, C., J. Rigaud, Philippe Camparo, et al.. (2013). Contribution 2013 du CCAFU au référentiel INCa : Sarcomes du rétropéritoine. Progrès en Urologie. 23. S161–S166.
10.
Xylinas, Évanguelos, Xavier Durand, Guillaume Ploussard, et al.. (2011). Evaluation of combined oncologic and functional outcomes after robotic-assisted laparoscopic extraperitoneal radical prostatectomy: Trifecta rate of achieving continence, potency and cancer control. Urologic Oncology Seminars and Original Investigations. 31(1). 99–103. 37 indexed citations
11.
Ramírez, J. M., et al.. (2011). Place du -2proPSA et de l’index phi dans la détection précoce du cancer de prostate : évaluation sur une série de 452 patients. Progrès en Urologie. 22(5). 279–283. 15 indexed citations
12.
Gillion, Norman, Évanguelos Xylinas, Xavier Durand, et al.. (2011). Mid‐term oncological control after laparoscopic radical cystectomy in men: a single‐centre experience. British Journal of Urology. 108(7). 1180–1184. 14 indexed citations
13.
Durand, Xavier, et al.. (2011). Actinomycose rénale d’aspect tumoral : à propos d’un cas. Progrès en Urologie. 21(8). 580–582. 1 indexed citations
14.
Tourtier, Jean Pierre, et al.. (2010). In flight auscultation: comparison of electronic and conventional stethoscopes. The American Journal of Emergency Medicine. 29(8). 932–935. 14 indexed citations
16.
Rigaud, J., C. Avancès, Philippe Camparo, et al.. (2010). Recommandations en Onco-Urologie 2010 : Tumeurs malignes du pénis. Progrès en Urologie. 20. S279–S289. 9 indexed citations
17.
Xylinas, Évanguelos, Guillaume Ploussard, Xavier Durand, et al.. (2010). Low pretreatment total testosterone (<3 ng/mL) predicts extraprostatic disease in prostatectomy specimens from patients with preoperative localized prostate cancer. British Journal of Urology. 107(9). 1400–1403. 47 indexed citations
18.
Xylinas, Évanguelos, Guillaume Ploussard, Xavier Durand, et al.. (2010). Evaluation of Combined Oncological and Functional Outcomes After Radical Prostatectomy: Trifecta Rate of Achieving Continence, Potency and Cancer Control—A Literature Review. Urology. 76(5). 1194–1198. 27 indexed citations
19.
Durand, Xavier. (2008). La relation pédagogique contrôleur de gestion – opérationnels : enjeux et déterminants. RePEc: Research Papers in Economics. 1 indexed citations
20.
Durand, Xavier, et al.. (2004). [Anatomical basis of lymph node dissection in prostate cancer].. PubMed. 14(2). 252–4. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026